Britain’s drug regulator authorized the Alzheimer’s drug Kisunla on Wednesday, but the government received’t be purchasing it following an unbiased watchdog company explained the therapy isn’t definitely worth the Value to taxpayersFifty years back, Philadelphia jail officers ended a healthcare tests method that experienced permitted a Univ